OsteoPhilicity
PEEK spinal implants with improved bone in-growth capability.
- Stage Product In Development
- Industry Biotechnology
- Location San Francisco, CA, USA
- Currency USD
- Founded May 2018
- Employees 2
- Incorporation Type LLC
- Website http://-
Company Summary
Over 65 million adults in the US suffer from chronic back pain. 1 million of them will undergo spinal fusion surgery. 10% of these patients will need revision because of implant failure. At over $100,000 per surgery, failed implants cause a $10 billion burden on our healthcare system every year. We are on a mission to stop this from happening. Our patented technology processes existing spinal implants to help them perform better and not fail.
Team
-
CEO2x entrepreneur, strong proponent of lean-startup practices.
3 years of experience in medical device innovation, healthcare market research, identifying product-market fit, and GTM strategy.
10+ years of experience in product development, design for regulatory conformance. Successfully led development (from ideation to launch) of hardware/software products in aviation, satellite, telecom, 4k-2k video streaming, ed-tech, and mHealth industries. -
Dr. Saadyah AverickChief ScientistOver 64 peer-reviewed publications in the field of novel biomaterials, polymer hybrids, coatings for medical devices. Inventor of numerous patents, including Aqua-PEEK's underlying science, and the lead scientist at the Allegheny-Singer Research Institute's neuroscience research lab.
Advisors
-
Dr. Boyle ChengUnconfirmed
Dr. Keith LejeuneUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.